Quantcast

Latest Serotonin-norepinephrine reuptake inhibitor Stories

2011-03-01 07:00:00

ST. LOUIS, March 1, 2011 /PRNewswire/ -- Patients who start on generic antidepressants are as likely to keep taking their medication as prescribed as those who start on brand-name drugs, an Express Scripts (Nasdaq: ESRX) study shows. The company's analysis provides further proof that greater use of generics could significantly reduce wasteful healthcare spending while maintaining positive health outcomes. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) The study was...

2011-01-18 23:09:56

Women who were either in the transition to menopause or postmenopausal experienced a reduction in the frequency and severity of menopausal hot flashes with the use of the antidepressant medication escitalopram, compared to women who received placebo, according to a study in the January 19 issue of JAMA. "Hormonal agents have been the predominant therapy for menopausal hot flashes, but their use decreased substantially following the shifts in risk-benefit ratios that were identified in the...

2010-10-13 16:52:00

ST. LOUIS, Oct. 13 /PRNewswire-FirstCall/ -- At the Academy of Managed Care Pharmacy (AMCP) 2010 Educational Conference taking place in St. Louis this week, Express Scripts (Nasdaq: ESRX) will present research findings that spotlight new opportunities for driving down healthcare costs and providing increased value for health plan sponsors and patients. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO) (Logo:...

2dcbec35ddd2536dc123f32f2cb68ebb
2010-06-01 11:15:00

Consumer Reports said on Tuesday that Americans prefer drugs to talk therapy for depression, with about 80 percent taking a pill for the condition. The group found that the most popular class of drugs remains the so-called SSRIs like Prozac.  People found that newer and pricier antidepressants were less desirable because of the side effects. The consumer group found that patients benefited just as much from therapy. The surveyed said they improved just as much after seven or more...

2009-11-10 11:45:00

LAVAL, QC, Nov. 10 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced an article has been published in the international journal of neuropsychiatric medicine, CNS Spectrums October, 2009 issue (www.cnsspectrums.com), citing the potential benefit of its novel trazodone formulation, which contains Contramid(R). Labopharm's Contramid is the clinically validated proprietary technology that controls the release of active substances from oral medications to optimize...

2009-08-17 07:00:00

WALTHAM, Mass., Aug. 17 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although generic erosion will negatively impact the major depression drug market in the United States, patent protection of key blockbuster agents will help drive market growth in Europe and Japan through 2018. The new Pharmacor report entitled Major Depressive Disorder finds that sales of therapies for major depression in...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'